Levamisole is an antihelminthic drug used to treat parasitic infections in animals and humans. Like all pharmaceutical products, it may contain impurities that can affect its efficacy and safety. Levamisole impurities are unwanted substances that may be present in the drug product due to manufacturing processes or degradation of the active ingredient. These impurities can have adverse effects on the patient's health and may compromise the quality of the drug. Therefore, it is essential to monitor and control the levels of Levamisole impurities in pharmaceutical products to ensure their safety and efficacy.
